Related Scientific Literature
- Cross-reaction of sera from COVID-19 patients with SARS-CoV assays
- SARS-CoV-2 specific antibody responses in COVID-19 patients
- Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays
- Evaluation of nine commercial SARS-CoV-2 immunoassays
- Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment
- Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG
- Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
- Monitoring antibody response following SARS-CoV-2 infection: Diagnostic efficiency of four automated immunoassays
- Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
- Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
- Evaluation of commercially available immuno-magnetic agglutination and enzyme-linked immunosorbent assays for rapid point-of-care diagnostics of COVID-19
- Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays?
- Analytical and Clinical Evaluation of the Automated Elecsys Anti-SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer
- Current and Perspective Diagnostic Techniques for COVID-19
- Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)
- Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients
- Laboratory diagnosis of coronavirus disease-2019 (COVID-19)
- Closing the Serological Gap in the Diagnostic Testing for COVID-19: The Value of Anti-SARS-CoV-2 IgA Antibodies
- Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
- Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
- An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
- In vitro diagnostics of coronavirus disease 2019: Technologies and application
- Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays
- Rapid quantification of SARS-CoV-2-neutralizing antibodies using propagation-defective vesicular stomatitis virus pseudotypes
- Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies
- Performance evaluation of serological assays to determine the immunoglobulin status in SARS-CoV-2 infected patients
- Assay Techniques and Test Development for COVID-19 Diagnosis.
- Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection
- Validation of a commercially available SARS-CoV-2 serological immunoassay
- Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
- Review of Current Advances in Serologic Testing for COVID-19
- SARS-CoV-2 and the COVID-19 disease: a mini review on diagnostic methods.
- Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study
- Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
- Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
- Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies.
- Evaluation of the Quotient® MosaiQ™ COVID-19 antibody microarray for the detection of IgG and IgM antibodies to SARS-CoV-2 virus in humans
- Performance of a qualitative rapid chromatographic immunoassay to diagnose COVID-19 in patients in a middle-income country
- Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests
- Evaluation of serological tests for SARS-CoV-2: Implications for serology testing in a low-prevalence setting
- Evaluation of six commercial mid to high volume antibody and six point of care lateral flow assays for detection of SARS-CoV-2 antibodies
- Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples
- EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)
- Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study
- Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event
- Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study.
- Evaluation of ELISA tests for the qualitative determination of IgG, IgM and IgA to SARS-CoV-2
- Comparison of SARS-CoV-2 serological tests with different antigen targets
- Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays
- Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with
- Overcoming Supply Shortage for SARS-CoV-2 Detection by RT-qPCR.
- Variable Performance in 6 Commercial SARS-CoV-2 Antibody Assays May Affect Convalescent Plasma and Seroprevalence Screening.